
AI-based health startup Healthify has merged with New York-based Berry Street in an all-stock deal, effectively becoming a US company with its India business as a subsidiary, Livemint reports. Healthify founder Tushar…
AI-based health startup Healthify has merged with New York-based Berry Street in an all-stock deal, effectively becoming a US company with its India business as a subsidiary, Livemint reports. Healthify founder Tushar Vashisht will serve as co-CEO alongside Berry Street founder Noah Kotlove. Financial details were not disclosed.

The merger pairs Healthify's AI platform with Berry Street's insurance and dietitian network. Vashisht told Livemint the move addresses Healthify's insurance gap in the US, while Berry Street gets an AI boost. Inc42 reports the merged entity will build an 'insurance-covered AI metabolic health platform' for the US market. Healthify investors, including Khosla Ventures and Chiratae Ventures, continue in the merged firm.
Vashisht said a US public offering is possible but at least 24 months away. An IPO of the Indian business is now unlikely but not ruled out, Livemint reports. Healthify plans to deepen its India presence through B2B partnerships and offline centres.
Both Livemint and Inc42 present the merger as a straightforward business deal without critical scrutiny. Livemint leads with the structural shift to a US company and quotes Vashisht on the rationale, while Inc42 emphasises the AI-insurance combination and platform goals. Neither source examines investor terms, valuation, or the risk of the India business being sidelined. The balanced reading: this is a pragmatic play for US insurance access, but the lack of deal details leaves success metrics unclear. The next concrete step is the merged entity's first quarterly results, likely in late 2025.
Coverage: 2 sources, 2 neutral
Sources (2): livemint.com (neutral report), inc42.com (neutral report)
This story was synthesised by AI from the 2 sources linked above.